The electrophysiology business Abbott (NYSE:ABT) built around its $250 million acquisition of Topera Medical this month warned physicians about the risk that the splines on some of its Firmap catheters could fracture. Abbott EP said it received 16 reports of catheter spline fracture from October 2013 to April 18, for an incidence rate of less than 0.4%. There […]
Topera Medical
Abbott, GE Healthcare ink afib deal
Medtech M&A: Tips from the front lines
S2N recently hosted an informal gathering of emerging med tech CEOs, a sort of group therapy session for people suffering from the form of temporary insanity that makes one want to be a healthcare entrepreneur.
Ishrak: ‘With COV We’ll do for ORs what we’ve done for cath labs’ | The week in medtech M&A
CardioMEMS, Nevro among top 20 VC-backed healthcare exits of 2014
At least 4 medtech exits were significant enough to make the cut for the top 20 venture capital-backed healthcare exits of 2014, according to research firm CB Insights.
Abbott closes $250m Topera buyout
Plan for Medtronic-Covidien management structure unveiled | The week in medtech M&A
Abbott buys into electrophysiology with $250m Topera acquisition
Topera lands FDA win for next-gen 3D Mapping System
Topera Medical landed 510(k) clearance from the FDA for the latest incarnation of its 3D Mapping System, featuring the RhythmView workstation and FIRMap diagnostic catheter.
The imaging system uses electrical signals, captured by a multipolar electrophysiology catheter, and creates a 3D image that can more accurately map cardiac arrhythmias.
Topera lands CE Mark, 510(k) clearance for heart catheter
Topera said it landed a pair of regulatory wins for its FIRMap catheter.
The Palo Alto, Calif.-based medical device company said it won the CE Mark approval in the European Union and 510(k) clearance from the FDA for the device.
Topera details $25M Series C round | Wall Street Beat
Topera said a new backer, New Enterprise Assoc., led a $25 million Series C round first reported by MassDevice.com last month, with an unnamed "strategic industry partner" joining the round.
